BCAL Diagnostics Limited (BDX.AX)
AUD 0.09
(-2.17%)
AUD 0.09
(-2.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -6.4 Million AUD | -26.44% |
| 2023 | -5.06 Million AUD | -49.51% |
| 2022 | -3.38 Million AUD | -122.0% |
| 2021 | -1.52 Million AUD | -118.99% |
| 2020 | -696.36 Thousand AUD | -61.96% |
| 2019 | -429.95 Thousand AUD | 8.06% |
| 2018 | -467.63 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -1.99 Million AUD | 17.02% |
| 2024 Q2 | -2.4 Million AUD | -100.0% |
| 2024 FY | -6.4 Million AUD | -26.44% |
| 2024 Q1 | -1.2 Million AUD | 53.56% |
| 2024 Q4 | -1.99 Million AUD | 0.0% |
| 2023 FY | -5.06 Million AUD | -49.51% |
| 2023 Q4 | -2.59 Million AUD | -100.0% |
| 2023 Q3 | -1.29 Million AUD | 47.57% |
| 2023 Q2 | -2.47 Million AUD | -100.0% |
| 2023 Q1 | -1.23 Million AUD | 40.29% |
| 2022 Q3 | -1.03 Million AUD | 21.4% |
| 2022 FY | -3.38 Million AUD | -122.0% |
| 2022 Q2 | -1.31 Million AUD | -100.0% |
| 2022 Q1 | -658.11 Thousand AUD | 48.6% |
| 2022 Q4 | -2.06 Million AUD | -100.0% |
| 2021 Q4 | -1.28 Million AUD | -100.0% |
| 2021 FY | -1.52 Million AUD | -118.99% |
| 2021 Q1 | -122.34 Thousand AUD | 38.68% |
| 2021 Q2 | -244.68 Thousand AUD | -100.0% |
| 2021 Q3 | -640.14 Thousand AUD | -161.62% |
| 2020 Q3 | -99.76 Thousand AUD | 79.92% |
| 2020 Q1 | -248.41 Thousand AUD | 0.0% |
| 2020 Q4 | -199.52 Thousand AUD | -100.0% |
| 2020 Q2 | -496.83 Thousand AUD | -100.0% |
| 2020 FY | -696.36 Thousand AUD | -61.96% |
| 2019 FY | -429.95 Thousand AUD | 8.06% |
| 2018 FY | -467.63 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Australian Clinical Labs Limited | 23.93 Million AUD | 126.741% |
| Genetic Signatures Limited | -17.86 Million AUD | 64.169% |
| Genetic Technologies Limited | -12.01 Million AUD | 46.741% |
| Healius Limited | -645.8 Million AUD | 99.009% |
| Imagion Biosystems Limited | -12.47 Million AUD | 48.691% |
| Integral Diagnostics Limited | -60.69 Million AUD | 89.456% |
| INOVIQ Ltd | -6.55 Million AUD | 2.352% |
| Microba Life Sciences Limited | -19.93 Million AUD | 67.9% |
| Monash IVF Group Limited | -6.52 Million AUD | 1.943% |
| Rhythm Biosciences Limited | -6.85 Million AUD | 6.659% |
| Sonic Healthcare Limited | 511.09 Million AUD | 101.252% |